US2018071269A1PendingUtilityA1
Therapeutical methods, formulations and nutraceutical formulations
Est. expiryAug 12, 2035(~9.1 yrs left)· nominal 20-yr term from priority
Inventors:Tianxin Wang
A61K 31/12A61K 36/66A61K 31/4375A61K 36/38A61K 2300/00A61K 31/138A61K 31/7028A61K 31/135A61K 31/4525A61K 36/9066A61K 31/122A61K 31/343A61K 45/06
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides compositions and methods for the prevention, treatment, or management of sexual dysfunction, such as premature ejaculation. The method comprises administering an effective amount of tetrahydropalmatine or its derivative or Rhizoma Corydalis extract containing composition to a human male on an as-needed basis shortly before sexual activity to delay ejaculation.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of managing sexual dysfunction or improving sexual control in a mammal in need of treatment comprising administering on an as-needed basis to the mammal a composition comprising tetrahydropalmatine and serotonin reuptake inhibitor in a therapeutically effective amount.
2 . The method of claim 1 , wherein the mammal is a human male.
3 . The method of claim 1 , wherein the serotonin reuptake inhibitor is selected from a group consisting of St. John's Wort extract, hyperforin, paroxetine, sertraline, dapoxetine, escitalopram and citalopram.
4 . A method of managing sexual dysfunction or improving sexual control in a mammal in need of treatment comprising administering on an as-needed basis to the mammal a composition comprising Corydalis Yanhusuo extract in a therapeutically effective amount.
5 . The method of claim 4 , wherein the composition further comprise St. John's Wort extract.
6 . The method of claim 4 , wherein the composition further comprise curcuminoid.
7 . A formulation for delaying ejaculation comprising Corydalis extract or tetrahydropalmatine, curcuminoid and at least one agent selected from a group consisting of paroxetine, sertraline, dapoxetine, Escitalopram, Citalopram and St. John's Wort extract.
8 . The formulation of claim 7 wherein the curcuminoid is selected from a group consisting of curcumin, desmethoxycurcumin, bis-desmethoxycurcumin, tetrahydrocurcuminoid, curcumin glucuronide, curcumin sulfate, hexahydrocurcumin or combinations thereof.
9 . The formulation of claim 7 , wherein the St. John's Wort extract is rich in hyperforin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.